Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $126.94 in the prior trading day, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $128.39, up 1.14%. In other words, the price has increased by $1.14 from its previous closing price. On the day, 0.87 million shares were traded. SRPT stock price reached its highest trading level at $128.59 during the session, while it also had its lowest trading level at $125.3401.
Ratios:
Our goal is to gain a better understanding of SRPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.19.
On June 26, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $172 to $176.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $157.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $157 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when Estepan Ian Michael sold 5,985 shares for $137.36 per share. The transaction valued at 822,100 led to the insider holds 33,946 shares of the business.
Estepan Ian Michael bought 5,985 shares of SRPT for $822,130 on Aug 30 ’24. On Aug 16 ’24, another insider, Chambers Michael Andrew, who serves as the Director of the company, bought 37,038 shares for $133.80 each. As a result, the insider paid 4,955,728 and bolstered with 284,034 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 12244079616 and an Enterprise Value of 12170653696. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 317.40, and their Forward P/E ratio for the next fiscal year is 11.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.14 while its Price-to-Book (P/B) ratio in mrq is 11.36. Its current Enterprise Value per Revenue stands at 8.087 whereas that against EBITDA is 156.536.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is -9.46%, while the 200-Day Moving Average is calculated to be 2.80%.
Shares Statistics:
The stock has traded on average 1.48M shares per day over the past 3-months and 744590 shares per day over the last 10 days, according to various share statistics. A total of 93.73M shares are outstanding, with a floating share count of 89.52M. Insiders hold about 6.13% of the company’s shares, while institutions hold 92.49% stake in the company. Shares short for SRPT as of 1723680000 were 6730587 with a Short Ratio of 4.55, compared to 1721001600 on 7332218. Therefore, it implies a Short% of Shares Outstanding of 6730587 and a Short% of Float of 7.380000000000001.
